Skip to content

The efficacy of a walking program for osteoarthritis of the knee

The impact of a community-based aerobic walking program for older individuals with mild to moderate knee osteoarthritis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN09193542
Enrollment
240
Registered
2006-12-27
Start date
2007-01-01
Completion date
Unknown
Last updated
2016-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis of the knee Musculoskeletal Diseases Arthritis

Interventions

1. Long-term structured aerobic walking program and educational pamphlet: walking program (45 minutes per session, three sessions a week during 18 months) 2. Long-term structured aerobic walking and b

Sponsors

University of Ottawa (Canada)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Male and female patients with osteoarthritis of the knee 2. 60 years and older 3. Pain for at least last 3 months

Exclusion criteria

Exclusion criteria: 1. Participation during the previous six months in regular Physical Activity (PA) or aerobic sports more than or equal to two times per week for more than 20 minutes per session 2. Presence of pain at rest or at night 3. Current rehabilitation treatment or previous corticosteroids injection within the last 12 months or any other pain-related treatment besides medication for arthritis 4. Uncontrolled hypertension: Systolic Blood Pressure (BP) more than 160 mmHg 5. Individuals with obesity (Body Mass Index [BMI] more than 30 kg/m^2) 6. Other illness, judged by the patient or study physician to make participation in this study inadvisable 7. Significant cognitive deficit resulting in an inability to understand or comply with instructions 8. Surgery planned in the next year 9. Intention to move away from Ottawa in the next year 10. Inability to communicate in English or French 11. Unwillingness to sign informed consent

Design outcomes

Primary

MeasureTime frame
1. The Arthritis Impact Measurement Scale (AIMS2), each 3 months during 18 months 2. The Short Form health survey (SF-36), each 3 months during 18 months

Secondary

MeasureTime frame
1. Overall adherence and maintenance of physical activity (the number of walking sessions attended divided by the number of walking sessions prescribed), every 3 months during 18 months 2.Change in level of PA measured using the seven-day Physical Activity Recall (PAR), each 3 months during 18 months 3. Self-efficacy capacity will be measured using the Arthritis Self-Efficacy Scale (ASES), each 3 months during 18 months 4. Aerobic capacity (Volume of Oxygen inspired by the body in one minute [VO2max]), each 6 months during 18 months 5. Walking endurance (six-minute walk-test), each 3 months during 18 months 6. Blood pressure and heart rate, each 3 months during 18 months 7. Functional status will be measured using the Western Ontario and McMaster University Osteoarthritis Index (WOMAC) questionnaire, each 3 months during 18 months 8. Gait speed (time to walk six metres), each 3 months during 18 months 9. Resource utilisation, each 3 months during 18 months 10. Cost (i.e. time lost from paid work), each 3 months during 18 months 11. Quality-adjusted life expectancy (societal-preference-based values will be elicited indirectly through completion of the EuroQoL questionnaire [EQ-5D]), each 3 months during 18 months

Countries

Canada

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026